485 related articles for article (PubMed ID: 7723281)
1. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
[TBL] [Abstract][Full Text] [Related]
2. [The expression and significance of chromogranin A and synaptophysin in adrenal gland tumors].
Feng C; Li HZ; Yan WG; Luo YF; Cao JL
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):486-8. PubMed ID: 16188147
[TBL] [Abstract][Full Text] [Related]
3. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
4. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma.
Sangoi AR; McKenney JK
Am J Surg Pathol; 2010 Mar; 34(3):423-32. PubMed ID: 20154585
[TBL] [Abstract][Full Text] [Related]
5. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine differentiation in adrenocortical carcinoma. New immunohistochemical findings supported by electron microscopy.
Miettinen M
Lab Invest; 1992 Feb; 66(2):169-74. PubMed ID: 1735954
[TBL] [Abstract][Full Text] [Related]
7. Stathmin as a marker for malignancy in pheochromocytomas.
Björklund P; Cupisti K; Fryknäs M; Isaksson A; Willenberg HS; Akerström G; Hellman P; Westin G
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):27-30. PubMed ID: 19449284
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic profile of the adrenal gland: from physiology to pathological conditions.
Imperiale A; Elbayed K; Moussallieh FM; Reix N; Piotto M; Bellocq JP; Goichot B; Bachellier P; Namer IJ
Endocr Relat Cancer; 2013 Oct; 20(5):705-16. PubMed ID: 23921203
[TBL] [Abstract][Full Text] [Related]
9. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
[TBL] [Abstract][Full Text] [Related]
10. Histologic and immunohistochemical classification of 41 bovine adrenal gland neoplasms.
Grossi AB; Leifsson PS; Jensen HE; Vainer B; Iburg T
Vet Pathol; 2013 May; 50(3):534-42. PubMed ID: 23242804
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland.
Ueberberg B; Unger N; Sheu SY; Walz MK; Schmid KW; Saeger W; Mann K; Petersenn S
Horm Metab Res; 2008 Mar; 40(3):181-8. PubMed ID: 18246525
[TBL] [Abstract][Full Text] [Related]
12. Pathology of adrenal neoplasms.
Saeger W
Minerva Endocrinol; 1995 Mar; 20(1):1-8. PubMed ID: 7651277
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of pheochromocytomas.
Lloyd RV; Shapiro B; Sisson JC; Kalff V; Thompson NW; Beierwaltes WA
Arch Pathol Lab Med; 1984 Jul; 108(7):541-4. PubMed ID: 6203498
[TBL] [Abstract][Full Text] [Related]
14. Expression of intermediate filaments in neuroendocrine tumors.
Kimura N; Nakazato Y; Nagura H; Sasano N
Arch Pathol Lab Med; 1990 May; 114(5):506-10. PubMed ID: 2159272
[TBL] [Abstract][Full Text] [Related]
15. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration.
Fetsch PA; Powers CN; Zakowski MF; Abati A
Cancer; 1999 Jun; 87(3):168-72. PubMed ID: 10385449
[TBL] [Abstract][Full Text] [Related]
16. Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex.
Cote RJ; Cordon-Cardo C; Reuter VE; Rosen PP
Am J Pathol; 1990 May; 136(5):1077-84. PubMed ID: 1693469
[TBL] [Abstract][Full Text] [Related]
17. bcl-2 expression in normal adrenal glands and in adrenal neoplasms.
Fogt F; Vortmeyer AO; Poremba C; Minda M; Harris CA; Tomaszewski JE
Mod Pathol; 1998 Aug; 11(8):716-20. PubMed ID: 9720498
[TBL] [Abstract][Full Text] [Related]
18. High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2004 Dec; 10(24):8426-33. PubMed ID: 15623622
[TBL] [Abstract][Full Text] [Related]
19. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas.
Ilvesmäki V; Kahri AI; Miettinen PJ; Voutilainen R
J Clin Endocrinol Metab; 1993 Sep; 77(3):852-8. PubMed ID: 8370710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
